The estimated Net Worth of Ulrich Martin Fuhs is at least $1.96 millió dollars as of 8 May 2024. Ulrich Fuhs owns over 22,820 units of Alpine Immune Sciences Inc stock worth over $1,956,896 and over the last few years Ulrich sold ALPN stock worth over $0.
Ulrich has made over 1 trades of the Alpine Immune Sciences Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Ulrich exercised 22,820 units of ALPN stock worth $275,437 on 8 May 2024.
The largest trade Ulrich's ever made was exercising 22,820 units of Alpine Immune Sciences Inc stock on 8 May 2024 worth over $275,437. On average, Ulrich trades about 11,410 units every 0 days since 2024. As of 8 May 2024 Ulrich still owns at least 30,120 units of Alpine Immune Sciences Inc stock.
You can see the complete history of Ulrich Fuhs stock trades at the bottom of the page.
Ulrich's mailing address filed with the SEC is C/O ALPINE IMMUNE SCIENCES, INC., 188 EAST BLAINE STREET, SUITE 200, SEATTLE, WA, 98102.
Over the last 7 years, insiders at Alpine Immune Sciences Inc have traded over $91,012,519 worth of Alpine Immune Sciences Inc stock and bought 8,061,426 units worth $69,477,679 . The most active insiders traders include Peter A. Thompson, Advisors Llc Orbi Med Capit... és James N Topper. On average, Alpine Immune Sciences Inc executives and independent directors trade stock every 37 days with the average trade being worth of $18,201,670. The most recent stock trade was executed by Stanford L Peng on 8 May 2024, trading 271,792 units of ALPN stock currently worth $668,608.
founded in 2015 by a team responsible for the fda's approval of the world's first cancer immunotherapy and experts in the field of recombinant protein based immunotherapies, alpine immune sciences was created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer, autoimmune disorders, and other diseases. traded on nasdaq under ticker alpn.
Alpine Immune Sciences Inc executives and other stock owners filed with the SEC include: